The Infinium Global Diversity Array with Enhanced PGx Content represents the most comprehensive genotyping microarray on the market for supporting pharmacogenomic research in addition to polygenic risk score development, ancestry determination, and genetic disease research. It is built on an eight-sample BeadChip that contains more than 1.9 million markers and supports interrogation of high-impact PGx genes that have historically been hard to discern like CYP2D6, CYP2B6, and TPMT. Additionally, optional interpretation software provides a report that contains metabolizer status and star allele calls. Visit illumina.com/PGx to learn more about why Infinium technology from Illumina is perfectly suited for your pharmacogenomic research needs. Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM